PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
37.12%
Net income growth above 1.5x MRVL's 17.13%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.26%
Negative yoy D&A while MRVL is 2.98%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
120.83%
Well above MRVL's 99.36% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
17.19%
SBC growth while MRVL is negative at -13.45%. John Neff would see competitor possibly controlling share issuance more tightly.
-153.88%
Negative yoy working capital usage while MRVL is 147.40%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-129.40%
Both yoy AR lines negative, with MRVL at -121.88%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-37.36%
Negative yoy inventory while MRVL is 100.54%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-209.91%
Negative yoy AP while MRVL is 141.43%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-292.59%
Negative yoy usage while MRVL is 169.55%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
99.15%
Some yoy increase while MRVL is negative at -71.34%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-66.82%
Negative yoy CFO while MRVL is 187.52%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
12.50%
Lower CapEx growth vs. MRVL's 31.72%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
18.91%
Some yoy expansion while MRVL is negative at -58.43%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
9.86%
Below 50% of MRVL's 47.45%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
111.64%
Lower net investing outflow yoy vs. MRVL's 2817.24%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
241.35%
Issuance growth of 241.35% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-13.17%
Both yoy lines negative, with MRVL at -19.67%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.